Comprehensive Analysis of the Global Lupus Nephritis Market along with the study of the regional Markets.
Latest
industry research report on: Global Lupus Nephritis Market | Industry
Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth,
Segmentation, Parameters, Forecasts
Lupus nephritis
is inflammation of the kidney that is caused by systemic lupus
erythematous (SLE). Also called lupus, SLE is an autoimmune disease
where the immune system turns against the body, affecting vital organs.
While the primary cause of the disease is unknown, it is expected that
factors such as viruses, infections, pollutants, and toxic chemicals,
along with family history plays a role in causing the disease. The
disease is more common in women compared to men. Kidney damage from
lupus erythematosus can vary from mild to severe. In lupus nephritis,
glomeruli or the filtering units are damaged. As a result, waste from
the blood does not get filtered. Lupus nephritis happens when lupus
involves the kidneys. When the kidneys are inflamed, they cannot
function normally and can leak protein. If not controlled, lupus
nephritis can lead to kidney failure.
The
treatment for Lupus Nephritis is based upon on its type, which is
determined by the biopsy. Since, symptoms and severity vary from person
to person, treatments are individually tailored to meet a person's
particular circumstances.
The
global Lupus Nephritis market is set to experience favourable growth
driven by factors such as increasing African-American population, rising
health care expenditure and accelerating economic growth. The major
trends observed in the market are new drugs under pipeline for Lupus
Nephritis, increasing research grants with rising public awareness about
the disease. However, the growth of this budding market will be
hindered by stringent regulations, associated risk and high cost.
The
report “Global Lupus Nephritis Market: Industry Analysis & Outlook
(2021-2030)” analyses the development of this market, with focus on the
U.S, Europe and Japan markets. The major trends, growth drivers as well
as issues being faced by the market are discussed in detail in this
report. The five major players: Aurinia Pharmaceuticals Inc., Roche
Holding AG, Bristol-Myers Squibb, GlaxoSmithKline Plc. and AstraZeneca
are being profiled along with their key financials and strategies for
growth. The report contains a comprehensive analysis of the global Lupus
Nephritis market along with the study of the regional markets.
Table of Contents
1. Overview
1.1 Introduction
1.2 Symptoms
1.3 Classification
1.4 Treatment
2. Global Market Analysis
2.1 Global Lupus Nephritis Patient Population Forecast
2.2 Global Lupus Nephritis Market Forecast by Value
2.3 Global Lupus Nephritis Market by Region
3. Regional Market Analysis
3.1 The U.S.
3.1.1 The U.S. SLE Patient Population Forecast
3.1.2 The U.S. Lupus Nephritis Patient Population Forecast
3.1.3 The U.S. Lupus Nephritis Market Forecast by Value
3.2 Europe
3.2.1 Europe Lupus Nephritis Patient Population Forecast
3.2.2 Europe Lupus Nephritis Market Forecast by Value
3.3 Japan
3.3.1 Japan Lupus Nephritis Patient Population Forecast
3.3.2 Japan Lupus Nephritis Market Forecast by Value
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time
and money for our clients. We are a one stop solution for all your
research needs, our main offerings are syndicated research reports,
custom research, subscription access and consulting services. We serve
all sizes and types of companies spanning across various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Comments
Post a Comment